Language bias in randomised controlled trials published in English and German

Lancet

Volumn 350, Issue 9074, 1997, Pages 326-329

  Egger, Matthias ^a   Zellweger Zähner, Tanja ^c   Schneider, Martin ^c   Junker, Christoph ^c   Lengeler, Christian ^b   Antes, Gerd ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EUROPE; GERMANY; LANGUAGE; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS;

EID: 0343471474     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)02419-7     Document Type: Article

References (32)

1. Anon. Cochrane's legacy. Lancet 1992; 340: 1131-32.
2. Mulrow CD Rationale for systematic reviews. BMJ. 309:1994;597-599.
3. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR Publication bias in clinical research. Lancet. 337:1991;867-872.
4. Simes RJ Confronting publication bias: a cohort design formeta-analysis. Stat Med. 6:1987;11-29.
5. Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith H Publication bias in clinical trials. Control Clin Trials. 8:1987;343-353.
6. Gøtzsche PC Reference bias in reports of drug trials. BMJ. 295:1987;654-656.
7. Egger M, Davey Smith G. Meta-analysis: bias in location and selection of studies. BMJ 1997 (in press).
8. Huston P, Moher D Redundancy, disaggregation, and the integrity of medical research. Lancet. 347:1996;1024-1026.
9. Anon. Evidence-based medicine, in its place. Lancet 1995; 346: 785.
10. Grégoire G, Derderian F, Le Lorier J Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemol. 48:1995;159-163.
11. Moher D, Fortin P, Jadad ARet al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 347:1996;363-366.
12. Chalmers I, Dickersin K, Chalmers TC Getting to grips with Archie Cochrane's agenda. BMJ. 305:1992;786-788.
13. Egger M, Zellweger T, Antes G Randomised trials in German-language journals. Lancet. 347:1996;1047-1048.
14. The Cochrane Controlled Trials Register. In: The Cochrane Library. CDROM and online. Cochrane Collaboration; issue 1. Oxford: Update Software, 1997.
15. Chalmers I, Adams M, Dickersin Ket al. A cohort study of summary reports of controlled trials. JAMA. 263:1990;1401-1405.
16. Jadad AR, Moore RA, Carrol Det al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 17:1996;1-12.
17. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 16:1995;62-73.
18. Institute for Scientific Information. 1994 Science Citation Index. Journal citation reports: a bibliometric analysis of science journals in the ISI database. Philadelphia: Institute for Scientific Information, 1995.
19. Dickersin K, Yuan-I M, Meinert CL Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA. 267:1992;374-378.
20. Anon. Manuscript guideline. Diabetologia 1984; 25: 4A.
21. Begg CB, Cho M, Eastwood Set al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 276:1996;637-639.
22. Kleijnen J, Knipschild P, ter Riet G Clinical trials of homoeopathy. BMJ. 302:1991;316-323.
23. Kleijnen J, Knipschild P Ginkgo biloba. Lancet. 340:1992;1136-1139.
24. Kleijnen J, Knipschild P The comprehensiveness of Medline and Embase computer searches. Pharmaceutisch Weekblad Sci Edn. 14:1992;316-320.
25. Jurincic-Winkler CD, Horlbeck R, von der Kammer H, Scheit KH, Klippel KF Adjuvante Immuntherapie mit Keyhole Limpet Hemocyanin (KLH) beim Nierenzellkarzinom der Kategorie PT2 N+ und PT3-4. No-N+, Mo. Wien Klin Wochenschr. 14:1994;455-458.
26. Flamm J, Fischer M Komplette Androgenblockade (Orchiektomie+Flutamid) versus Androgenblockade mit Zytostase (Orchiektomie+Estramustin) in der Behandlung des virginellen fortgeschrittenen Prostatakarzinoms. Wien Klin Wochenschr. 100:1988;589-592.
27. Bayerdörffer E, Kasper G, Pirlet T, Sommer A, Ottenjann R Ofloxacin in der Therapie Campylobacter-pylori-positiver Ulcera duodeni. Deutsch Med Wochenschr. 112:1987;1407-1411.
28. Lemmel EM, Bach GL, Bolten Wet al. Immunodulierende Therapie der chronischen Polyarthritis mit Thymopentin. Deutsch Med Wochenschr. 113:1988;172-176.
29. Zöllner N The Clinical Investigator. Clin Invest. 70:1992;1-2.
30. Ganten D The Journal of Molecular Medicine: tradition, continuity and renaissance. J Mol Med. 73:1995;1-3.
31. International Committee of Medical Journal Editors Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 324:1991;424-428.
32. Gasel B, Weng Y Medical journals in China. Ann Intern Med. 112:1990;70-72.